We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The government has immediately authorised the NHS to use the world’s first coronavirus treatment proven to reduce the risk of death.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
From October 2014 Dexamethasone 4 mg/ml injection (Organon Laboratories Limited) will be replaced by Dexamethasone 3.8 mg/ml solution for injection (Aspen Pharma Trading Limited).
Check the veterinary product information database to find out if a medicine is safe to use on your pet or has been removed from sale
The DHSC-led COVID-19 Antivirals and Therapeutics Taskforce co-ordinates the end-to-end provision of treatments for coronavirus (COVID-19) in the UK so that patients get access to safe and effective treatments as soon as possible.
The most commonly encountered drugs currently controlled under the misuse of drugs legislation.
A summary of letters and drug alerts recently sent to healthcare professionals.
Groundbreaking new treatment to be rolled out to vulnerable hospital patients from next week.
Thousands more NHS patients who are hospitalised due to COVID-19 will be able to receive the life-saving treatment tocilizumab, the government has announced.
The Antivirals Taskforce will identify treatments for UK patients who have been exposed to COVID-19 to stop the infection spreading and speed up recovery time.
Clinical trial results show the drugs reduce risk of death by 24% for critically ill patients and time spent in intensive care by up to 10 days.
Allergan Pharmaceuticals Ireland is further recalling batches due to the possibility that a single loose silicone particle of approximately 300 microns in diameter may become detached.
The world’s most innovative treatments for COVID-19 will soon be fast-tracked through the UK’s clinical trial system, as the government announces funding for the most promising treatments.
Coadministration of a corticosteroid with an HIV-treatment-boosting agent may increase the risk of adrenal suppression due to a pharmacokinetic interaction.
The Secretary of State for Health and Social Care Matt Hancock spoke at the Association of the British Pharmaceutical Industry (ABPI) annual conference.
NHS to build on power of data used to save lives during the pandemic.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.